Kyle Chiang
Profilo
Kyle Chiang is currently an Origination Partner at Flagship Pioneering, Inc. since 2023.
Formerly, Dr. Chiang was Chief Operating Officer at LogicBio Therapeutics, Inc. from 2020 to 2021, Associate Director-Clinical Sciences at aTyr Pharma, Inc., and Chief Operating Officer at Montai Health, Inc. Education includes a doctorate from The Scripps Research Institute and an undergraduate degree from the University of California.
Ultime notizie su Kyle Chiang
Posizioni attive di Kyle Chiang
| Società | Posizione | Inizio |
|---|---|---|
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Investitore di Private Equity | 01/01/2021 |
Precedenti posizioni note di Kyle Chiang
| Società | Posizione | Fine |
|---|---|---|
Montai Health, Inc.
Montai Health, Inc. Develops drugs and related software platform | Direttore operativo | 28/10/2025 |
| LOGICBIO THERAPEUTICS, INC. | Direttore operativo | 28/05/2021 |
| ATYR PHARMA, INC. | Corporate Officer/Principal | 01/10/2016 |
Formazione di Kyle Chiang
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
aTyr Pharma, Inc.
aTyr Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a bio therapeutics company that discovers and develops medicines based on novel biological pathways | Health Technology |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Finance |
University of California
University of California Functions as a College/University | |
LogicBio Therapeutics, Inc.
LogicBio Therapeutics, Inc. Develops genetic medicine for pediatric patients and rare diseases | |
Montai Health, Inc.
Montai Health, Inc. Develops drugs and related software platform |
















